Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Dynavax Stock Jumped Today

TheMotleyFool

0 0

Shares of Dynavax Technologies (NASDAQ: DVAX) were jumping 7.1% higher as of 3:38 p.m. EDT on Thursday. The gain came after Valneva reported positive initial results from the first part of a phase 1/2 clinical study evaluating its COVID-19 vaccine candidate VLA2001. This experimental vaccine uses Dynavax's CpG 1018 adjuvant.

Valneva tested three doses of VLA2001 in the phase 1/2 study. The company reported especially encouraging results for the high dose of its COVID-19 vaccine candidate. All participants in the study who received the high dose developed significant levels of IgG antibodies to the SARS-CoV-2 virus spike protein.

Image source: Getty Images.

Source Fool.com

Like: 0

DVAX

Share